If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Update this Profile
Get Updates
11
Followers on Owler
Pulmagen Therapeutics
develops novel therapies to treat chronic respiratory diseases including asthma, severe asthma and COPD...
Read more
Overview
Competitors
News & Insights
Pulmagen Therapeutics
develops novel therapies to treat chronic respiratory diseases including asthma, severe asthma and COPD...
Read more
CEO
Christopher Philip Ashton
CEO Approval Rating
69/100
Weigh In
2010
Slough
England
Private
Pharmaceuticals & Biotechnology
Pharmaceuticals
2834
NAICS listing
http://www.pulmagen.com/
Est. Annual Revenue
$100K-5.0M
Agree?
Yes
No
Est. Employees
250-500
Agree?
Yes
No
News
Latest News
Oct 10, 2018
BioPortfolio
Pulmagen Therapeutics: Pulmagen Therapeutics LLP Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 24072018 Prices from USD $250
Aug 24, 2018
BioPortfolio
Pulmagen Therapeutics: Pulmagen Therapeutics LLP Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 09052018 Prices from USD $250
Mar 24, 2018
BioPortfolio
Pulmagen Therapeutics: Pulmagen Therapeutics LLP Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14032018 Prices from USD $250
Dec 01, 2017
BioPortfolio
Pulmagen Therapeutics: Pulmagen Therapeutics LLP Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 09112017 Prices from USD $250
Oct 14, 2017
BioPortfolio
Pulmagen Therapeutics: Pulmagen Therapeutics LLP Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14092017 Prices from USD $250
Mar 25, 2017
BioPortfolio
Pulmagen Therapeutics: Pulmagen Therapeutics LLP Pharmaceuticals Healthcare Deals and Alliances Profile Updated 21022017 Prices from USD $250
Dec 14, 2016
FierceBiotechIT
Pulmagen Therapeutics: Pulmagen med passes phase 2 asthma test, seeks partner for late-stage trials
Dec 13, 2016
BioSpace
Pulmagen Therapeutics: Positive Phase II In Eosinophilic Asthma For Teijin Pharma
Nov 17, 2016
BioPortfolio
Pulmagen Therapeutics: Pulmagen Therapeutics LLP Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250
May 13, 2015
PR-INSIDE.COM
Press Release: Pulmagen Therapeutics : Newly released market study: Pulmagen Therapeutics LLP - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Follow and Get Alerts
Pulmagen Therapeutics Competitors
1
Follow
2
Follow
3
Follow
4
Follow
5
Follow
6
Follow
7
Follow
8
Follow
9
Follow
10
Follow
Unlock 13 + competitors
Trending Companies